HK1199267A1 - Method for reducing the thromboembolic potential of a plasma-derived immunoglobulin composition - Google Patents

Method for reducing the thromboembolic potential of a plasma-derived immunoglobulin composition

Info

Publication number
HK1199267A1
HK1199267A1 HK14112763.4A HK14112763A HK1199267A1 HK 1199267 A1 HK1199267 A1 HK 1199267A1 HK 14112763 A HK14112763 A HK 14112763A HK 1199267 A1 HK1199267 A1 HK 1199267A1
Authority
HK
Hong Kong
Prior art keywords
plasma
reducing
immunoglobulin composition
derived immunoglobulin
thromboembolic
Prior art date
Application number
HK14112763.4A
Other languages
English (en)
Chinese (zh)
Inventor
Wolfgang Teschner
Harald Arno Butterweck
Bernhard Koelbl
Lucia Hofbauer
Hans-Peter Schwarz
Original Assignee
Baxter Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Int filed Critical Baxter Int
Publication of HK1199267A1 publication Critical patent/HK1199267A1/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065Purification, fragmentation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Transplantation (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
HK14112763.4A 2011-08-26 2014-12-22 Method for reducing the thromboembolic potential of a plasma-derived immunoglobulin composition HK1199267A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161527974P 2011-08-26 2011-08-26
PCT/US2012/052567 WO2013033042A1 (en) 2011-08-26 2012-08-27 Method for reducing the thromboembolic potential of a plasma-derived immunoglobulin composition

Publications (1)

Publication Number Publication Date
HK1199267A1 true HK1199267A1 (en) 2015-06-26

Family

ID=46970397

Family Applications (1)

Application Number Title Priority Date Filing Date
HK14112763.4A HK1199267A1 (en) 2011-08-26 2014-12-22 Method for reducing the thromboembolic potential of a plasma-derived immunoglobulin composition

Country Status (20)

Country Link
US (1) US9403899B2 (ko)
EP (1) EP2748193B1 (ko)
JP (1) JP6165143B2 (ko)
KR (1) KR101949553B1 (ko)
CN (1) CN103874708B (ko)
AR (1) AR087953A1 (ko)
AU (1) AU2012300220C1 (ko)
BR (1) BR112014004445B1 (ko)
CA (1) CA2846599A1 (ko)
CL (1) CL2014000480A1 (ko)
CO (1) CO6920256A2 (ko)
EA (1) EA030251B1 (ko)
ES (1) ES2624485T3 (ko)
HK (1) HK1199267A1 (ko)
IL (1) IL231083B (ko)
MX (1) MX349005B (ko)
MY (1) MY165164A (ko)
SG (1) SG11201400233TA (ko)
TW (1) TWI610937B (ko)
WO (1) WO2013033042A1 (ko)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2013203043B2 (en) * 2013-03-15 2016-10-06 Takeda Pharmaceutical Company Limited Methods to produce a human plasma-derived igg preparation enriched in brain disease-related natural iggs
EP3118210B1 (en) * 2014-03-11 2019-11-13 Green Cross Holdings Corporation Method for purifying immunoglobulin
ES2785375T3 (es) 2014-03-11 2020-10-06 Green Cross Holdings Corp Procedimiento de purificación de inmunoglobulina
EP3275897A1 (en) * 2016-07-27 2018-01-31 Biotest AG Process for preparing immunoglobulin compositions
KR101941974B1 (ko) * 2016-11-18 2019-01-24 주식회사 녹십자 혈장 단백질 정제시 fxi의 제거방법
US11814442B2 (en) 2017-06-12 2023-11-14 Kamada Ltd. Immunoglobulin compositions and process for obtaining the same
TW202400621A (zh) * 2022-05-02 2024-01-01 日商武田藥品工業股份有限公司 經由超濾自血漿製備科恩池濃縮物之方法

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE348942B (ko) 1970-06-02 1972-09-18 Statens Bakteriologiska Labor
JPS5598117A (en) * 1979-01-17 1980-07-25 Chemo Sero Therapeut Res Inst Purification of gamma-globulin derivative
US4639513A (en) 1984-02-02 1987-01-27 Cuno Inc. Intravenously injectable immunoglobulin G (IGG) and method for producing same
DK166763B1 (da) 1983-03-16 1993-07-12 Immuno Ag Immunoglobulin-g-holdig fraktion
US4482483A (en) 1983-04-06 1984-11-13 Armour Pharmceutical Company Composition of intravenous immune globulin
EP0168506B2 (en) 1984-07-07 1998-01-07 Armour Pharma GmbH Process for preparing gamma globulin suitable for intravenous administration
DE3640513A1 (de) 1986-11-27 1988-06-09 Biotest Pharma Gmbh Verfahren zur herstellung eines virussicheren, lagerstabilen und intravenoes vertraeglichen immunglobulin-g-praeparates
DE3641115A1 (de) 1986-12-02 1988-06-16 Lentia Gmbh Verfahren zur herstellung eines intravenoes anwendbaren und in fluessiger form stabilen immunglobulins
US5177194A (en) 1990-02-01 1993-01-05 Baxter International, Inc. Process for purifying immune serum globulins
FR2706466B1 (fr) 1993-06-14 1995-08-25 Aetsrn Concentré d'immunoglobulines G à usage thérapeutique et procédé de production dudit concentré.
DE59309332D1 (de) 1993-12-27 1999-03-04 Rotkreuzstiftung Zentratrallab Verfahren zur Herstellung eines Konzentrates von Anti-D-Immunoglobulin G und pharmazeutische Zusammensetzung, die dieses enthält
GB9610992D0 (en) 1996-05-24 1996-07-31 Glaxo Group Ltd Concentrated antibody preparation
US6162904A (en) 1997-12-24 2000-12-19 Alpha Therapeutic Corporation Manufacturing method for intraveneously administrable immune globulin and resultant product
TR200100303T2 (tr) * 1998-06-09 2001-06-21 Statens Serum Institut Damardan uygulanacak immünoglobülinler üretmek için yöntem ve başka immünoglobülin ürünleri.
US6281336B1 (en) * 1998-06-09 2001-08-28 Statens Serum Institut Process for producing immunoglobulins for intravenous administration and other immunoglobulin products
SE0001128D0 (sv) * 2000-03-30 2000-03-30 Amersham Pharm Biotech Ab A method of producing IgG
CN102459331B (zh) * 2009-05-27 2015-01-28 巴克斯特国际公司 生产用于皮下使用的高度浓缩的免疫球蛋白制品的方法
IL212911A0 (en) * 2011-05-16 2011-07-31 Omrix Biopharmaceuticals Ltd Immunoglobulin reduced in thrombogenic contaminants and preparation thereof

Also Published As

Publication number Publication date
KR20140062088A (ko) 2014-05-22
JP2014525417A (ja) 2014-09-29
MX349005B (es) 2017-07-06
TWI610937B (zh) 2018-01-11
EA201400273A1 (ru) 2014-08-29
MY165164A (en) 2018-02-28
MX2014002204A (es) 2014-06-11
CO6920256A2 (es) 2014-04-10
BR112014004445B1 (pt) 2022-11-22
AR087953A1 (es) 2014-04-30
KR101949553B1 (ko) 2019-02-18
CN103874708B (zh) 2018-07-10
AU2012300220A1 (en) 2013-05-02
CA2846599A1 (en) 2013-03-07
CN103874708A (zh) 2014-06-18
WO2013033042A1 (en) 2013-03-07
SG11201400233TA (en) 2014-08-28
EP2748193A1 (en) 2014-07-02
US9403899B2 (en) 2016-08-02
JP6165143B2 (ja) 2017-07-19
IL231083A0 (en) 2014-03-31
AU2012300220B2 (en) 2015-09-10
CL2014000480A1 (es) 2014-10-03
TW201326192A (zh) 2013-07-01
BR112014004445A2 (pt) 2017-03-28
US20130058961A1 (en) 2013-03-07
AU2012300220C1 (en) 2016-11-10
ES2624485T3 (es) 2017-07-14
IL231083B (en) 2019-06-30
EP2748193B1 (en) 2017-02-01
EA030251B1 (ru) 2018-07-31

Similar Documents

Publication Publication Date Title
ZA201305971B (en) Method for the purification of biphephos
HK1223613A1 (zh) 用於製備取代的 -氟- -吡唑並吡啶類化合物的方法
IL232558B (en) A method for antibody purification
EP2742031A4 (en) PROCESS FOR PRODUCING BENZOXAZINE COMPOUNDS
IL227581B (en) A method for constructing certain coefficients
HUE043343T2 (hu) Eljárás hidrofluorolefinek elõállítására
EP2674204A4 (en) METHOD FOR CONTROLLING MAN-MACHINE INTERACTION AND APPLICATION OF SAID METHOD
HK1199267A1 (en) Method for reducing the thromboembolic potential of a plasma-derived immunoglobulin composition
EP2650276A4 (en) PROCESS FOR PRODUCTION OF -FLUOROALCOOL
PL2729233T3 (pl) Sposób kontrolowania mgły
HK1188133A1 (zh) 乳化組合物的製備方法
EP2728468A4 (en) METHOD FOR MODIFYING THE TRIM OF A THIRD PARTY APPLICATION
EP2682217A4 (en) METHOD FOR MANUFACTURING SLIDING ELEMENT
EP2708529A4 (en) PROCESS FOR PRODUCING PARTICLES
PL2748267T3 (pl) Sposób ochrony powierzchni
EP2743258A4 (en) PROCESS FOR PURIFYING LEVO-OXIRACETAM
EP2703408A4 (en) PROCESS FOR CLEANING ROCURONIUM BROMIDE
PL2797846T3 (pl) Sposób zwłókniania materiałów szklistych
PL2476684T3 (pl) Sposób wytwarzania alkilofosforanów
EP2752402A4 (en) METHOD OF PREPARING A 2-ALKENYLAMINE COMPOUND
SG10201602593SA (en) Method for welding renewable raw materials
EP2772544A4 (en) NEW CONNECTION AND METHOD FOR THE PRODUCTION THEREOF
PL2476685T3 (pl) Sposób wytwarzania alkilofosforanów
PL2476686T3 (pl) Sposób wytwarzania alkilofosforanów
EP2752401A4 (en) PROCESS FOR PRODUCING 2-ALKENYLAMINE COMPOUND

Legal Events

Date Code Title Description
CHRG Changes in the register

Free format text: CORRECTION OF NAME OF INVENTOR FROM HOFBAUER, LUCIA TO GNAUER, LUCIA